Basilea Pharmaceutica AG
Status: Publicly traded
Direct answer
Basilea Pharmaceutica AG is publicly traded on LSE under the ticker 0QNA.L.
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for...
Can you invest in Basilea Pharmaceutica AG?
Yes. Basilea Pharmaceutica AG trades publicly on LSE as 0QNA.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Basilea Pharmaceutica AG
Detailed equity research is provided by MarketSnap.